A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
doi: https://doi.org/10.1101/2021.03.06.21253051
Galit Perez
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
MN MATamar Banon
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
MScSivan Gazit
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
MD MAShay Ben Moshe
3Ben-Gurion University, Beer Sheva, Israel
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
MScJoshua Wortsman
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
MDDaniel Grupel
3Ben-Gurion University, Beer Sheva, Israel
MDAsaf Peretz
4Internal Medicine COVID-19 Ward, Samson Assuta Ashdod University Hospital, Ashdod Israel
MDAmir Ben Tov
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
MDGabriel Chodick
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
PhD MHAMiri Mizrahi-Reuveni
6Health Division, Maccabi Healthcare Services, Tel Aviv, Israel
MD MHATal Patalon
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
MDArticle usage
Posted March 08, 2021.
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
medRxiv 2021.03.06.21253051; doi: https://doi.org/10.1101/2021.03.06.21253051
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
medRxiv 2021.03.06.21253051; doi: https://doi.org/10.1101/2021.03.06.21253051
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)